<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35420443</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Pathological Characteristics of Echovirus 30 Infection in a Mouse Model.</ArticleTitle><Pagination><StartPage>e0012922</StartPage><MedlinePgn>e0012922</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00129-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00129-22</ELocationID><Abstract><AbstractText>Echovirus 30 (E30), a member of species B enterovirus, is associated with outbreaks of aseptic meningitis and has become a global health emergency. However, the pathogenesis of E30 remains poorly understood due to the lack of appropriate animal models. In this study, we established a mouse infection model to explore the pathogenicity of E30. The 2-day-old <i>IFNAR<sup>-/-</sup></i> mice infected with E30 strain WZ16 showed lethargy and paralysis, and some died. Obvious pathological changes were observed in the skeletal muscle, brain tissue, and other tissues, with the highest viral load in the skeletal muscles. Transcriptome analysis of brain and skeletal muscle tissues from infected mice showed that significant differentially expressed genes were enriched in complement response and neuropathy-related pathways. Using immunofluorescence assay, we found that the viral double-stranded RNA (dsRNA) was detected in the mouse brain region and could infect human glioma (U251) cells. These results indicated that E30 affects the nervous system, and they provide a theoretical basis for understanding its pathogenesis. <b>IMPORTANCE</b> Echovirus 30 (E30) infection causes a wide spectrum of diseases with mild symptoms, such as hand, foot, and mouth disease (HFMD), acute flaccid paralysis, and aseptic meningitis and other diseases, especially one of the most common pathogens causing aseptic meningitis outbreaks. We established a novel mouse model of E30 infection by inoculating neonatal mice with clinical isolates of E30 and observed the pathological changes induced by E30. Using the E30 infection model, we found complement responses and neuropathy-related genes in the mice tissues at the transcriptome level. Moreover, we found that the viral dsRNA localized in the mouse brain and could replicate in human glioma cell line U251 rather than in the neuroblastoma cell line, SK-N-SH.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jichen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Weifang Medical Universitygrid.268079.2, Weifang, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guoyan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Keyi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Huanhuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jinbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Zhenzhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hehe</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhijun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Weifang Medical Universitygrid.268079.2, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004457" MajorTopicYN="Y">Echovirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="Y">Glioma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008582" MajorTopicYN="N">Meningitis, Aseptic</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">animal model</Keyword><Keyword MajorTopicYN="N">echovirus 30</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>12</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35420443</ArticleId><ArticleId IdType="pmc">PMC9093115</ArticleId><ArticleId IdType="doi">10.1128/jvi.00129-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lefkowitz EJ, Dempsey DM, Hendrickson RC, Orton RJ, Siddell SG, Smith DB. 2018. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Res 46:D708&#x2013;D717. 10.1093/nar/gkx932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx932</ArticleId><ArticleId IdType="pmc">PMC5753373</ArticleId><ArticleId IdType="pubmed">29040670</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams MJ, Lefkowitz EJ, King AM, Harrach B, Harrison RL, Knowles NJ, Kropinski AM, Krupovic M, Kuhn JH, Mushegian AR, Nibert M, Sabanadzovic S, Sanfacon H, Siddell SG, Simmonds P, Varsani A, Zerbini FM, Gorbalenya AE, Davison AJ. 2016. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016). Arch Virol 161:2921&#x2013;2949. 10.1007/s00705-016-2977-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-2977-6</ArticleId><ArticleId IdType="pmc">PMC7086986</ArticleId><ArticleId IdType="pubmed">27424026</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjomaki V, Turkki P, Huttunen M. 2015. Infectious entry pathway of enterovirus B species. Viruses 7:6387&#x2013;6399. 10.3390/v7122945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122945</ArticleId><ArticleId IdType="pmc">PMC4690868</ArticleId><ArticleId IdType="pubmed">26690201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayawardena N, Burga LN, Poirier JT, Bostina M. 2019. Virus-receptor interactions: structural insights for oncolytic virus development. Oncolytic Virother 8:39&#x2013;56. 10.2147/OV.S218494.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OV.S218494</ArticleId><ArticleId IdType="pmc">PMC6825474</ArticleId><ArticleId IdType="pubmed">31754615</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkova E, Laassri M, Zagorodnyaya T, Petrovskaya S, Rodionova E, Cherkasova E, Gmyl A, Ivanova OE, Eremeeva TP, Lipskaya GY, Agol VI, Chumakov K. 2017. Pressure for pattern-specific intertypic recombination between Sabin polioviruses: evolutionary implications. Viruses 9:353. 10.3390/v9110353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9110353</ArticleId><ArticleId IdType="pmc">PMC5707560</ArticleId><ArticleId IdType="pubmed">29165333</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and Prevention. 2006. Enterovirus surveillance&#x2013;United States, 1970-2005. MMWR Surveill Summ 55:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YN, Jiang QW, Jiang RJ, Chen L, Perlin DS. 2005. Echovirus 30, Jiangsu Province, China. Emerg Infect Dis 11:562&#x2013;567. 10.3201/eid1104.040995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1104.040995</ArticleId><ArticleId IdType="pmc">PMC3320326</ArticleId><ArticleId IdType="pubmed">15829194</ArticleId></ArticleIdList></Reference><Reference><Citation>Savolainen C, Hovi T, Mulders MN. 2001. Molecular epidemiology of echovirus 30 in Europe: succession of dominant sublineages within a single major genotype. Arch Virol 146:521&#x2013;537. 10.1007/s007050170160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007050170160</ArticleId><ArticleId IdType="pubmed">11338388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortner B, Huang CW, Schmid D, Mutz I, Wewalka G, Allerberger F, Yang JY, Huemer HP. 2009. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol 81:317&#x2013;324. 10.1002/jmv.21374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21374</ArticleId><ArticleId IdType="pubmed">19107980</ArticleId></ArticleIdList></Reference><Reference><Citation>Broberg EK, Simone B, Jansa J, The EU/EEA Member State Contributors. 2018. Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018. Euro Surveill 23:1800537. 10.2807/1560-7917.ES.2018.23.44.1800537.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.44.1800537</ArticleId><ArticleId IdType="pmc">PMC6337069</ArticleId><ArticleId IdType="pubmed">30401013</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliam Leitch EC, Bendig J, Cabrerizo M, Cardosa J, Hyypia T, Ivanova OE, Kelly A, Kroes AC, Lukashev A, MacAdam A, McMinn P, Roivainen M, Trallero G, Evans DJ, Simmonds P. 2009. Transmission networks and population turnover of echovirus 30. J Virol 83:2109&#x2013;2118. 10.1128/JVI.02109-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02109-08</ArticleId><ArticleId IdType="pmc">PMC2643716</ArticleId><ArticleId IdType="pubmed">19091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Han Z, Wu H, Xu W, Yu D, Zhang Y. 2020. A large-scale outbreak of echovirus 30 in Gansu Province of China in 2015 and its phylodynamic characterization. Front Microbiol 11:1137. 10.3389/fmicb.2020.01137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01137</ArticleId><ArticleId IdType="pmc">PMC7297909</ArticleId><ArticleId IdType="pubmed">32587581</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Li D, Sun T, Du Y, Gao Y, Ding R, Ji W, Zhang W, Yang H, Chen S, Duan G. 2021. Pathological features of enterovirus 71-associated brain and lung damage in mice based on quantitative proteomic analysis. Front Microbiol 12:663019. 10.3389/fmicb.2021.663019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.663019</ArticleId><ArticleId IdType="pmc">PMC8249819</ArticleId><ArticleId IdType="pubmed">34220748</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778&#x2013;790. 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tryfonos C, Richter J, Koptides D, Yiangou M, Christodoulou CG. 2011. Molecular typing and epidemiology of enteroviruses in Cyprus, 2003-2007. J Med Microbiol 60:1433&#x2013;1440. 10.1099/jmm.0.029892-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.029892-0</ArticleId><ArticleId IdType="pubmed">21596905</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahm T, Frank F, Adams O, Lindner HA, Ishikawa H, Weiss C, Schwerk C, Schroten H, Tenenbaum T, Rudolph H. 2017. Sequential transmigration of polymorphonuclear cells and naive CD3(+) T lymphocytes across the blood-cerebrospinal-fluid barrier in vitro following infection with Echovirus 30. Virus Res 232:54&#x2013;62. 10.1016/j.virusres.2017.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.01.024</ArticleId><ArticleId IdType="pubmed">28161477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahm T, Adams O, Boettcher S, Diedrich S, Morozov V, Hansman G, Fallier-Becker P, Schadler S, Burkhardt CJ, Weiss C, Stump-Guthier C, Ishikawa H, Schroten H, Schwerk C, Tenenbaum T, Rudolph H. 2018. Strain-dependent effects of clinical echovirus 30 outbreak isolates at the blood-CSF barrier. J Neuroinflammation 15:50. 10.1186/s12974-018-1061-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1061-4</ArticleId><ArticleId IdType="pmc">PMC5819246</ArticleId><ArticleId IdType="pubmed">29463289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinz MJ, Davenport AP. 2005. Emerging roles of apelin in biology and medicine. Pharmacol Ther 107:198&#x2013;211. 10.1016/j.pharmthera.2005.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2005.04.001</ArticleId><ArticleId IdType="pubmed">15907343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoji T, Saito R, Chonan M, Shibahara I, Sato A, Kanamori M, Sonoda Y, Kondo T, Ishii N, Tominaga T. 2016. Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models. Neuro Oncol 18:1120&#x2013;1128. 10.1093/neuonc/now023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/now023</ArticleId><ArticleId IdType="pmc">PMC4933484</ArticleId><ArticleId IdType="pubmed">26917236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari SK, Wang S, Smith D, Carlin AF, Rana TM. 2021. Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell-derived lung and cerebral organoids. Stem Cell Rep 16:437&#x2013;445. 10.1016/j.stemcr.2021.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.02.005</ArticleId><ArticleId IdType="pmc">PMC7879814</ArticleId><ArticleId IdType="pubmed">33631122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Leao IC, Coleman EM, Broughton RS, Hildreth JE. 2009. Deficiency of Niemann-Pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments. J Virol 83:7982&#x2013;7995. 10.1128/JVI.00259-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00259-09</ArticleId><ArticleId IdType="pmc">PMC2715784</ArticleId><ArticleId IdType="pubmed">19474101</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Kennett ML, Campbell JJ, Carpenter MS, Schnurr D, Pallansch MA. 1999. Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol 37:3928&#x2013;3933. 10.1128/JCM.37.12.3928-3933.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.12.3928-3933.1999</ArticleId><ArticleId IdType="pmc">PMC85848</ArticleId><ArticleId IdType="pubmed">10565909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. 2012. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 86:11967&#x2013;11976. 10.1128/JVI.00902-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-12</ArticleId><ArticleId IdType="pmc">PMC3486452</ArticleId><ArticleId IdType="pubmed">22951825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Devi S, Cardosa MJ, Wong KT. 2010. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 84:661&#x2013;665. 10.1128/JVI.00999-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00999-09</ArticleId><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Grimes KA, Kim K, Branche E, Bakkenist CJ, DePas WH, Shresta S, Coyne CB. 2021. Human FcRn expression and type I interferon signaling control echovirus 11 pathogenesis in mice. PLoS Pathog 17:e1009252. 10.1371/journal.ppat.1009252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009252</ArticleId><ArticleId IdType="pmc">PMC7875378</ArticleId><ArticleId IdType="pubmed">33513208</ArticleId></ArticleIdList></Reference><Reference><Citation>Morosky S, Wells AI, Lemon K, Evans AS, Schamus S, Bakkenist CJ, Coyne CB. 2019. The neonatal Fc receptor is a pan-echovirus receptor. Proc Natl Acad Sci USA 116:3758&#x2013;3763. 10.1073/pnas.1817341116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1817341116</ArticleId><ArticleId IdType="pmc">PMC6397586</ArticleId><ArticleId IdType="pubmed">30808762</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 356:1226&#x2013;1234. 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Mao Q, Li S, Gao F, Zhao H, Liu Y, Wan J, Ye X, Xia N, Cheng T, Liang Z. 2016. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6. Antiviral Res 134:50&#x2013;57. 10.1016/j.antiviral.2016.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.08.025</ArticleId><ArticleId IdType="pubmed">27582066</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao CC, Liou AT, Chang YS, Wu SY, Chang CS, Lee CK, Kung JT, Tu PH, Yu YY, Lin CY, Lin JS, Shih C. 2014. Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J Virol 88:12485&#x2013;12499. 10.1128/JVI.00692-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00692-14</ArticleId><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="pubmed">25142603</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JJ. 2018. Blood-brain barrier (BBB) and the complement landscape. Mol Immunol 102:26&#x2013;31. 10.1016/j.molimm.2018.06.267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2018.06.267</ArticleId><ArticleId IdType="pubmed">30007547</ArticleId></ArticleIdList></Reference><Reference><Citation>Volle R, Archimbaud C, Couraud PO, Romero IA, Weksler B, Mirand A, Pereira B, Henquell C, Peigue-Lafeuille H, Bailly JL. 2015. Differential permissivity of human cerebrovascular endothelial cells to enterovirus infection and specificities of serotype EV-A71 in crossing an in vitro model of the human blood-brain barrier. J Gen Virol 96:1682&#x2013;1695. 10.1099/vir.0.000103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000103</ArticleId><ArticleId IdType="pubmed">25711966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R. 2011. Enterovirus infections of the central nervous system. Virology 411:288&#x2013;305. 10.1016/j.virol.2010.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.12.014</ArticleId><ArticleId IdType="pmc">PMC3060663</ArticleId><ArticleId IdType="pubmed">21251690</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas MC, Alexopoulos H, Spaeth PJ. 2020. Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Rev Neurol 16:601&#x2013;617. 10.1038/s41582-020-0400-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0400-0</ArticleId><ArticleId IdType="pmc">PMC7528717</ArticleId><ArticleId IdType="pubmed">33005040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinkovits G, Mez&#x151; B, R&#xe9;ti M, M&#xfc;ller V, Iv&#xe1;nyi Z, G&#xe1;l J, Gopcsa L, Rem&#xe9;nyi P, Szathm&#xe1;ry B, Lakatos B, Szl&#xe1;vik J, Bobek I, Proh&#xe1;szka ZZ, F&#xf6;rh&#xe9;cz Z, Csuka D, Hurler L, Kajd&#xe1;csi E, Cervenak L, Kiszel P, Masszi T, V&#xe1;lyi-Nagy I, Proh&#xe1;szka Z. 2021. Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front Immunol 12:663187. 10.3389/fimmu.2021.663187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.663187</ArticleId><ArticleId IdType="pmc">PMC8027327</ArticleId><ArticleId IdType="pubmed">33841446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtovic L, Beeson JG. 2021. Complement factors in COVID-19 therapeutics and vaccines. Trends Immunol 42:94&#x2013;103. 10.1016/j.it.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7733687</ArticleId><ArticleId IdType="pubmed">33402318</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandesande H, Laajala M, Kantoluoto T, Ruokolainen V, Lindberg AM, Marjomaki V. 2020. Early entry events in echovirus 30 infection. J Virol 94:e00592-20. 10.1128/JVI.00592-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00592-20</ArticleId><ArticleId IdType="pmc">PMC7307138</ArticleId><ArticleId IdType="pubmed">32295914</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DM, Hixon AM, Oldfield LM, Zhang Y, Novotny M, Wang W, Das SR, Shabman RS, Tyler KL, Scheuermann RH. 2018. Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells. mBio 9:e01954-18. 10.1128/mBio.01954-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01954-18</ArticleId><ArticleId IdType="pmc">PMC6191546</ArticleId><ArticleId IdType="pubmed">30327438</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Su R, Wang W, Liang Y, Zeng X, Shereen MA, Bashir N, Zhang Q, Zhao L, Wu K, Liu Y, Wu J. 2019. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production. PLoS Pathog 15:e1008142. 10.1371/journal.ppat.1008142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008142</ArticleId><ArticleId IdType="pmc">PMC6932824</ArticleId><ArticleId IdType="pubmed">31730654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiatr M, Figueiredo R, Stump-Guthier C, Winter P, Ishikawa H, Adams O, Schwerk C, Schroten H, Rudolph H, Tenenbaum T. 2020. Polar infection of echovirus-30 causes differential barrier affection and gene regulation at the blood-cerebrospinal fluid barrier. Int J Mol Sci 21:6268. 10.3390/ijms21176268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176268</ArticleId><ArticleId IdType="pmc">PMC7503638</ArticleId><ArticleId IdType="pubmed">32872518</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, McManus RM, Latz E. 2018. Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 19:610&#x2013;621. 10.1038/s41583-018-0055-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0055-7</ArticleId><ArticleId IdType="pubmed">30206330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Yu X, Zhang S, Shu K. 2021. Targeting the complement pathway in malignant glioma microenvironments. Front Cell Dev Biol 9:657472. 10.3389/fcell.2021.657472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.657472</ArticleId><ArticleId IdType="pmc">PMC8047198</ArticleId><ArticleId IdType="pubmed">33869223</ArticleId></ArticleIdList></Reference><Reference><Citation>Maenpaa A, Junnikkala S, Hakulinen J, Timonen T, Meri S. 1996. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Am J Pathol 148:1139&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1861510</ArticleId><ArticleId IdType="pubmed">8644856</ArticleId></ArticleIdList></Reference><Reference><Citation>VanBlargan LA, Himansu S, Foreman BM, Ebel GD, Pierson TC, Diamond MS. 2018. An mRNA vaccine protects mice against multiple tick-transmitted flavivirus infections. Cell Rep 25:3382&#x2013;3392.e3. 10.1016/j.celrep.2018.11.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.11.082</ArticleId><ArticleId IdType="pmc">PMC6353567</ArticleId><ArticleId IdType="pubmed">30566864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>